IFNβ-Induced


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Nov 2022
Historique:
received: 14 10 2022
revised: 17 11 2022
accepted: 24 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

IFN-I is the key regulatory component activating and modulating the response of innate and adaptive immune system to bacterial as well as viral pathogens. IFN-I promotes the expression of IFN-induced genes (ISG) and, consequently, the production of chemokines, e.g., CXCL10. Those chemokines control migration and localization of immune cells in tissues, and, thus, are critical to the function of the innate immune system during infection. Consequently, the regulation of IFN-I signaling is essential for the proper induction of an immune response. Our previous study has shown that E3 ubiquitin ligase Pellino3 positively regulates IFNβ expression and secretion. Herein, we examined the role of Pellino3 ligase in regulating

Identifiants

pubmed: 36499241
pii: ijms232314915
doi: 10.3390/ijms232314915
pmc: PMC9741470
pii:
doi:

Substances chimiques

Chemokine CXCL10 0
CXCL10 protein, human 0
Interferon Type I 0
Ligases EC 6.-
Interferon-beta 77238-31-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Centre, Poland
ID : UMO-2015/18/E/NZ3/00695

Références

Pathog Immun. 2016 Spring;1(1):107-116
pubmed: 27500281
Eur J Immunol. 2010 Nov;40(11):3150-60
pubmed: 20957750
EMBO J. 2013 Oct 16;32(20):2751-63
pubmed: 24065129
Oxid Med Cell Longev. 2021 Jul 1;2021:6668463
pubmed: 34306313
Am J Physiol Lung Cell Mol Physiol. 2005 Jul;289(1):L85-95
pubmed: 15764644
J Microbiol Biotechnol. 2021 Jul 28;31(7):942-948
pubmed: 34099596
J Biol Chem. 1996 Aug 23;271(34):20494-500
pubmed: 8702790
J Biol Chem. 2001 Apr 27;276(17):13756-61
pubmed: 11278812
Retrovirology. 2013 Dec 03;10:146
pubmed: 24299076
Int J Cancer. 2015 Feb 1;136(3):572-83
pubmed: 24806531
Int J Mol Sci. 2020 Nov 25;21(23):
pubmed: 33255528
J Biol Chem. 1999 Nov 5;274(45):32507-11
pubmed: 10542297
Cell Signal. 2012 Jun;24(6):1141-9
pubmed: 22330071
Inflammation. 2013 Apr;36(2):364-71
pubmed: 23065240
J Virol. 2014 Feb;88(3):1582-90
pubmed: 24257594
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13631-6
pubmed: 11095741
Hepatology. 2004 May;39(5):1220-9
pubmed: 15122750
Nat Commun. 2019 Aug 2;10(1):3471
pubmed: 31375662
Nat Immunol. 2012 Nov;13(11):1055-62
pubmed: 23042151
J Biol Chem. 1993 Mar 25;268(9):6677-88
pubmed: 8454640
J Biol Chem. 2005 Sep 9;280(36):31530-6
pubmed: 16009713
Front Immunol. 2017 Jan 26;8:29
pubmed: 28184222
Am J Pathol. 2009 Nov;175(5):2023-33
pubmed: 19808647
J Vasc Res. 2007;44(1):51-60
pubmed: 17167270
Nat Commun. 2019 Jul 2;10(1):2921
pubmed: 31266943
J Biol Chem. 2005 Jul 8;280(27):25849-53
pubmed: 15883164
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
J Interferon Cytokine Res. 2011 Jul;31(7):553-9
pubmed: 21631354
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
J Interferon Res. 1994 Dec;14(6):357-63
pubmed: 7897255
Ann Neurol. 1996 Oct;40(4):618-27
pubmed: 8871582
Viruses. 2011 Jun;3(6):920-40
pubmed: 21994762
Int J MS Care. 2020 Jul-Aug;22(4):165-172
pubmed: 32863784
Nat Immunol. 2005 Jan;6(1):49-56
pubmed: 15568025
Front Immunol. 2021 Jan 20;11:615603
pubmed: 33552080
J Biol Chem. 2005 Jul 29;280(30):27759-68
pubmed: 15917247
J Biol Chem. 2011 Dec 30;286(52):44750-63
pubmed: 22065573
J Immunol. 2002 Apr 1;168(7):3195-204
pubmed: 11907072
Cytokine. 2001 Jun 7;14(5):272-82
pubmed: 11444907

Auteurs

Edyta Makuch (E)

Łukasiewicz Research Network-PORT Polish Center for Technology Development, 54-066 Wrocław, Poland.

Izabella Jasyk (I)

Łukasiewicz Research Network-PORT Polish Center for Technology Development, 54-066 Wrocław, Poland.
Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.

Anna Kula (A)

Łukasiewicz Research Network-PORT Polish Center for Technology Development, 54-066 Wrocław, Poland.
Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.

Tomasz Lipiński (T)

Łukasiewicz Research Network-PORT Polish Center for Technology Development, 54-066 Wrocław, Poland.

Jakub Siednienko (J)

Łukasiewicz Research Network-PORT Polish Center for Technology Development, 54-066 Wrocław, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH